Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

This study has been completed.
Information provided by (Responsible Party):
Lawrence Hookey, Queen's University Identifier:
First received: May 19, 2009
Last updated: September 14, 2011
Last verified: September 2011
This study aims to further define the appropriate population for Pico-Salax, a purgative used prior to colonoscopy. Patients over the age of 70 years with normal renal function scheduled for colonoscopy will receive Pico-Salax and have pre and post preparation bloodwork and electrocardiograms (ECGs).

Colon Cleansing

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Safety, Efficacy, and Tolerance of Pico-Salax for Colon Cleansing Prior to Colonoscopy in an Elderly Population

Resource links provided by NLM:

Further study details as provided by Queen's University:

Primary Outcome Measures:
  • serum electrolyte changes pre and post preparation [ Time Frame: 2 months ]

Estimated Enrollment: 50
Study Start Date: January 2009
Study Completion Date: September 2011
Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
elderly patients
patients older than 70 years with normal renal function


Ages Eligible for Study:   70 Years and older   (Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patients older than 70 scheduled for colonoscopy

Inclusion Criteria:

  • >70 years

Exclusion Criteria:

  • renal dysfunction
  • congestive heart failure
  • ileus
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00906217

Sponsors and Collaborators
Queen's University
Principal Investigator: Lawrence Hookey, MD Queen's University
  More Information

Responsible Party: Lawrence Hookey, assistant professor of medicine, Queen's University Identifier: NCT00906217     History of Changes
Other Study ID Numbers: Hookey Picosalax Elderly Trial
Study First Received: May 19, 2009
Last Updated: September 14, 2011

Keywords provided by Queen's University:
elderly processed this record on April 28, 2017